Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model
- PMID: 8290546
- PMCID: PMC42965
- DOI: 10.1073/pnas.91.2.444
Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model
Abstract
A synthetic peptide corresponding to an immunodominant epitope of lymphocytic choriomeningitis virus glycoprotein (LCMV GP) was used to prime or to tolerize CD8+ T cells in vivo, dependent on mode of immunization. Peptide-specific tolerance was then examined in transgenic mice expressing LCMV GP in the beta islet cells of the pancreas; these mice develop CD8+ T-cell-mediated diabetes within 8-14 days after LCMV infection. Specific peptide-induced tolerance prevented autoimmune destruction of beta islet cells and diabetes in this transgenic mouse model.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials